TILT Biotherapeutics is a clinical-stage biotechnology company creating the next generation of immunotherapies for solid tumors, utilizing patented TILT® technology that involves modified viruses to enhance the immune response against cancer
TILT Biotherapeutics is a clinical-stage biotechnology company creating the next generation of immunotherapies for solid tumors, utilizing patented TILT® technology that involves modified viruses to enhance the immune response against cancer.